Products
Glide Pharma is building a pipeline of in-house and partnered products based on its proprietary Glide technology. Glide SDI is an innovative new needle-free injection system that allows the delivery of drugs, vaccines and other active pharmaceutical ingredients in solid form. Glide offers significant benefits and opportunities to drug developers, healthcare providers, patients and their carers.
The chart below summarizes the current internal development programmes underway:
Application |
Funding Source |
Development Stage |
Glide fentanyl |
Internal |
Successful phase I clinical study completed |
Glide octreotide |
Internal |
Successful phase I clinical study completed |
Glide sumatriptan |
Internal |
Non-clinical |
Glide vaccines |
Internal |
Non-clinical |
In addition, Glide Pharma is also engaged in a number of collaborations and funded feasibility studies with pharmaceutical and large biotech partners.
